Showing results (441-450 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|August 3, 2023
METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanismXiaoxue Hou, Yuwen Li, Jiali Song, et al.
Hepatology Communications|July 17, 2023
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participantsAlexander J Thompson, Kathy Jackson, Sara Bonanzinga, et al.
Hepatology Communications|June 22, 2023
Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver diseaseLina Gruneau, Stergios Kechagias, Per Sandström, et al.
Hepatology Communications|June 14, 2023
Single ethanol binge causes severe liver injury in mice fed Western dietYu-Te Yeh, Xiangdong Wu, Yinyan Ma, et al.
Hepatology Communications|March 27, 2026
Liver test pattern and histologic bile duct injury do not predict response to treatment of immunotherapy hepatotoxicityBenjamin Rabin, Michael Li, Jordan S Sack, et al.
Hepatology Communications|April 1, 2026
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotypeTamir Diamond, Catherine A Chapin, Caroline J Diorio, et al.
Hepatology Communications|April 13, 2026
The global epidemiology of hepatocellular carcinomaMuhammad Ali Butt, Elizabeth S Aby, Jose D Debes
Hepatology Communications|April 13, 2026
CD14+CD16- monocytes exhibit NF-κB hyperactivation in biliary atresia: Clinical association and murine therapeutic validationJiaming Chang, Sizhe Liu, Xiaobin Wu, et al.
Hepatology Communications|April 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studiesStuart C Gordon, Alejandra Villamil, Ira M Jacobson, et al.
Pageof 179